Cargando…

非小细胞肺癌肺部寡转移的手术和热消融治疗现状与展望

Oligometastasis can be regarded as a transition state between early metastasis and extensive metastasis (limited tumor load, unique tumor biological behavior). Due to the relatively limited number of metastatic foci and the number of affected organs, there is a potential chance of cure after active...

Descripción completa

Detalles Bibliográficos
Autor principal: LIU, Baodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial board of Chinese Journal of Lung Cancer 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106791/
https://www.ncbi.nlm.nih.gov/pubmed/37035886
http://dx.doi.org/10.3779/j.issn.1009-3419.2023.106.06
_version_ 1785026483436126208
author LIU, Baodong
author_facet LIU, Baodong
author_sort LIU, Baodong
collection PubMed
description Oligometastasis can be regarded as a transition state between early metastasis and extensive metastasis (limited tumor load, unique tumor biological behavior). Due to the relatively limited number of metastatic foci and the number of affected organs, there is a potential chance of cure after active systemic and local treatment. With the rapid development of molecular targeted drug therapy and immunotherapy, local therapy for oligometastatic non-small cell lung cancer (NSCLC), including oligorecurrence and oligoprogression, has received increasing attention. In this paper, the relevant research, efficacy, influencing factors, safety and indications of local therapy such as surgery and thermal ablation were discussed.
format Online
Article
Text
id pubmed-10106791
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Editorial board of Chinese Journal of Lung Cancer
record_format MEDLINE/PubMed
spelling pubmed-101067912023-04-18 非小细胞肺癌肺部寡转移的手术和热消融治疗现状与展望 LIU, Baodong Zhongguo Fei Ai Za Zhi Review Oligometastasis can be regarded as a transition state between early metastasis and extensive metastasis (limited tumor load, unique tumor biological behavior). Due to the relatively limited number of metastatic foci and the number of affected organs, there is a potential chance of cure after active systemic and local treatment. With the rapid development of molecular targeted drug therapy and immunotherapy, local therapy for oligometastatic non-small cell lung cancer (NSCLC), including oligorecurrence and oligoprogression, has received increasing attention. In this paper, the relevant research, efficacy, influencing factors, safety and indications of local therapy such as surgery and thermal ablation were discussed. Editorial board of Chinese Journal of Lung Cancer 2023-03-20 /pmc/articles/PMC10106791/ /pubmed/37035886 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.106.06 Text en https://creativecommons.org/licenses/by/3.0/This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/.
spellingShingle Review
LIU, Baodong
非小细胞肺癌肺部寡转移的手术和热消融治疗现状与展望
title 非小细胞肺癌肺部寡转移的手术和热消融治疗现状与展望
title_full 非小细胞肺癌肺部寡转移的手术和热消融治疗现状与展望
title_fullStr 非小细胞肺癌肺部寡转移的手术和热消融治疗现状与展望
title_full_unstemmed 非小细胞肺癌肺部寡转移的手术和热消融治疗现状与展望
title_short 非小细胞肺癌肺部寡转移的手术和热消融治疗现状与展望
title_sort 非小细胞肺癌肺部寡转移的手术和热消融治疗现状与展望
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106791/
https://www.ncbi.nlm.nih.gov/pubmed/37035886
http://dx.doi.org/10.3779/j.issn.1009-3419.2023.106.06
work_keys_str_mv AT liubaodong fēixiǎoxìbāofèiáifèibùguǎzhuǎnyídeshǒushùhérèxiāoróngzhìliáoxiànzhuàngyǔzhǎnwàng